The Usnic Acid Analogue 4-FPBUA Enhances the Blood–Brain Barrier Function and Induces Autophagy in Alzheimer's Disease Mouse Models

SB Al Rihani, KH Elfakhri, HY Ebrahim… - ACS Chemical …, 2024 - ACS Publications
Preclinical and clinical studies have indicated that compromised blood–brain barrier (BBB)
function contributes to Alzheimer's disease (AD) pathology. BBB breakdown ranged from …

[HTML][HTML] Lysosomal proteomics reveals mechanisms of neuronal apoE4associated lysosomal dysfunction

EK Krogsaeter, J McKetney, A Marquez, Z Cakir… - bioRxiv, 2023 - ncbi.nlm.nih.gov
ApoE4 is the primary risk factor for Alzheimer's Disease. While apoE is primarily expressed
by astrocytes, AD pathology including endosomal abnormalities and mitochondrial …

Impact of Suramin on Key Pathological Features of Sporadic Alzheimer's Disease-Derived Forebrain Neurons

RA Culibrk, KA Ebbert, DJ Yeisley… - Journal of …, 2024 - content.iospress.com
Background: Alzheimer's disease (AD) is characterized by disrupted proteostasis and
macroautophagy (hereafter “autophagy”). The pharmacological agent suramin has known …

Membrane Interactions in Alzheimers Treatment Strategies with Multitarget Molecules

P Zambrano - arXiv preprint arXiv:2403.06331, 2024 - arxiv.org
Addressing Alzheimer's disease (AD) requires innovative strategies beyond current single-
target drugs. This Letter to the Editor suggests that multitarget molecules, especially those …

[引用][C] Membrane interactions in Alzheimer's disease treatment strategies with multitarget molecules.

P Zambrano - Bioorganic Chemistry, 2024 - europepmc.org
Membrane interactions in Alzheimer's disease treatment strategies with multitarget molecules.
- Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …